Clinical Trials Logo

Clinical Trial Summary

This is a phase Ib/IIa, single ascending dose study of the safety, tolerability and preliminary efficacy of sublingual (SL) Liraglutide in patients with type 2 diabetes mellitus (T2DM).


Clinical Trial Description

This Phase Ib/IIa study of SL liraglutide will be conducted at the Phase 1 Clinical Trial Center, Prince of Wales Hospital, Hong Kong. Study subjects will be patients with T2DM who have not previously received liraglutide. The study seeks to document the utility of a SL formulation of the approved active ingredient liraglutide, currently marketed in a subcutaneous (SC) formulation as Victoza®. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05268237
Study type Interventional
Source Biolingus
Contact Elaine YK Chow
Phone +852 35051642
Email e.chow@cuhk.edu.hk
Status Recruiting
Phase Phase 1/Phase 2
Start date April 25, 2023
Completion date July 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04940962 - Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion N/A
Completed NCT05359341 - Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients? N/A
Recruiting NCT04700813 - Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications
Completed NCT05413330 - Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes. Phase 2/Phase 3
Recruiting NCT04927377 - Accessible and Inclusive Diabetes Telecoaching Self-Management Program N/A
Completed NCT05585268 - Electronic Decision Support for Deprescribing in Patients on Hemodialysis N/A
Active, not recruiting NCT05088616 - Native American Diabetes Project N/A
Not yet recruiting NCT03273738 - Vascular and Metabolic Changes in Postmenopausal Diabetics
Active, not recruiting NCT04642911 - Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy
Withdrawn NCT04283617 - Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study N/A
Recruiting NCT04769687 - Symbiotics and Systemic Inflammation in Chronic Kidney Disease Phase 2
Withdrawn NCT06104358 - Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes Phase 2
Recruiting NCT03341793 - Impact of Changes in Muscle Secretome in the Remission of Type 2 Diabetes Mellitus Induced by Bariatric Surgery N/A
Not yet recruiting NCT06080802 - The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction Phase 2/Phase 3
Recruiting NCT04485845 - Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression Phase 4
Recruiting NCT05050500 - The Effect of Dapagliflozin on the Short-term Prognosis of Patients With Acute Myocardial Infarction Phase 4
Completed NCT04115657 - The Effect of Different Starches of Boba Pearls and Sugar Substitutes Used in Milk Tea on Glycaemia, Insulinaemia and Appetite Control (Pearl Study) N/A
Completed NCT06188572 - The Effect of Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality
Completed NCT04120844 - Effectiveness of Motivational Interviewing on Improving Care for Type 2 Diabetes Mellitus Patients in China N/A
Completed NCT05789706 - Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans N/A